Evogene (EVGN) Hits New 1-Year Low at $3.36

Shares of Evogene Ltd. (NASDAQ:EVGN) reached a new 52-week low on Wednesday . The company traded as low as $3.36 and last traded at $3.45, with a volume of 25900 shares. The stock had previously closed at $3.44.

A hedge fund recently raised its stake in Evogene stock. Vanguard Group Inc. boosted its stake in shares of Evogene Ltd. (NASDAQ:EVGN) by 4.2% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 436,225 shares of the biotechnology company’s stock after purchasing an additional 17,391 shares during the period. Vanguard Group Inc. owned approximately 1.70% of Evogene worth $2,443,000 at the end of the most recent quarter. Institutional investors and hedge funds own 30.94% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.com-unik.info/2017/12/22/evogene-evgn-hits-new-1-year-low-at-3-36.html.

Evogene Company Profile

Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.

What are top analysts saying about Evogene? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Evogene and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit